Hospital

A booster shot of the Johnson & Johnson single-shot vaccine administered 56 days after the initial shot provided 94% protection against COVID-19.

Although the advisory committee’s recommendation is not binding, the FDA will take their recommendation into consideration when making a final decision on authorization of the 50-µg booster dose.

A panel overview of the important topics happening in pharmacy, such as the role of technicians growing in the field, COVID-19’s impact on their work, and what they feel the value of a pharmacist is. Happy American Pharmacists Month!

Causes of atrial flutter include hypertension, cardiomyopathy, abnormal heart valve, hypertrophy, hyperthyroidism, and pulmonary embolism.

Lindy Bancke, PharmD, head of clinical development at Rebiotix Inc, said the clinical development program of RBX2660 is showing promise in the treatment of recurrent C. Difficile infection.

The agency has a 2-day meeting scheduled for this week for an independent advisory panel to discuss the available data.

Approximately 25% to 35% of new oncology therapies in development are oral medications.

Pembrolizumab (Keytruda) approved by FDA in combination with chemotherapy, with or without bevacizumab (Avastin), in patients with persistent, recurrent, or metastatic cervical cancer.

Early intervention with ocrelizumab resulted in a 35% reduction of risk in individuals with RMS who needed a walking aid over 7 and a half years.

Maralixibat decreases the reabsorption of bile acids from the terminal ileum for the treatment of cholestatic pruritus in patients with Alagille syndrome.

In an interview with Pharmacy Times®, Mitchell Barnett, PharmD, MS, associate director of the Iowa Prescription Monitoring Program for the Iowa Board of Pharmacy, and Mylo Wells, PharmD, owner of Wells Hometown Drug, discuss Iowa’s new drug disposal kit program and the impact it could have on the opioid epidemic.

According to GenSight, GS030 combines AAV2-based gene therapy with optogenetics to treat RP.

New therapeutics for prostate cancer must continue to be assessed for comparative safety and efficacy, as well as accessibility for patients.

In its most severe form, Guillain-Barre syndrome is a medical emergency.

Washington State University study results show that slumber-deprived individuals had more difficulty reducing the emotions they felt when so instructed than those who slept normally.

Abemaciclib (Verzenio) approved in combination with endocrine therapy for the adjuvant treatment of adult patients with HR–positive, HER2-negative, node-positive, early breast cancer at high risk of recurrence.

Adults 40 to 59 years of age should consult their clinician before taking aspirin, and adults 60 years of age and older should stop aspirin use for the prevention of cardiovascular disease.

Michael Frank, CEO of Revive Therapeutics, and Derrick Welsh, COO of Psilocin Pharma, a division of Revive Therapeutics, discuss clinical research investigating novel treatment targets for psilocybin, such as treatment-resistant depression in patients with cancer.

Pharmacy Times spoke with Dr. Jeffrey Akers, CEO of Pharmaceutical Services at Appalachian Regional Healthcare, about how integrated technology can empower pharmacists to prioritize patient care and safety and can help prevent harmful medication events from occurring.

Although October has long been celebrated as National Pharmacy Month, it is only in recent years that female pharmacists have been celebrated for their contributions to the profession and patient care.

The authors said stigmatization threatens societal cohesion during times of national upheaval, such as during a pandemic.

Jameshia Below, PharmD, assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains how oncologic emergencies present in patients, and how each type can be recognized.

Patients receiving sacituzumab govitecan also reported lower symptomatic impact of fatigue, pain, dyspnea, and insomnia.

People who inherit familial hypercholesterolemia from both parents usually develop symptoms in childhood.

Fluciclovine F 18 (Axumin), which is a radioactive diagnostic agent for injection that can be used to detect recurring prostate cancer.

The PROpel phase 3 trial met the primary endpoints of radiographic progressing-free for men with metastatic castration-resistant prostate when treated with Olaparib, combined with abiraterone.

The medication, which has been cleared as a treatment for the inflammatory disease of the throat, is under priority review by the agency.

There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.

The study aimed to examine the impact of masking and social distancing practices used to control the spread of COVID-19.